24小时热门版块排行榜    

查看: 609  |  回复: 3
本帖产生 1 个 翻译EPI ,点击这里进行查看
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

yin198716

新虫 (正式写手)

[求助] 求助翻译

Tumor angiogenesis is essential for tumor growth and metastasis and is triggered by a variety of proangiogenic factors, regulated by many angiogenic pathways. The most important and best characterized is the VEGF pathway . Blockade of VEGF signaling inhibits tumor angiogenesis and growth in various preclinical models and having systemic effects . The effect of anti-VEGF strategy has been validated in randomized phase III clinical trials. Disruption of VEGF signaling by using bevacizumab, a humanized anti-human VEGF antibody or sorafenib and sunitinib, 2 small chemical inhibitors of receptor-tyrosine kinases (RTK) including VEGF receptors  have yielded a significant improvement in progression-free survival but rarely in overall survival for patients with several types of cancers including metastatic colorectal cancer , advanced non–small cell lung cancer , metastatic breast cancer , advanced clear-cell renal-cell carcinoma  and advanced hepatocellular carcinoma .
Oncology
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

yin198716

新虫 (正式写手)

引用回帖:
2楼: Originally posted by 大猫1860 at 2013-04-07 17:51:28
增加金币我就翻译

翻译的好 给你30到40也不吝啬
Oncology
4楼2013-04-08 10:58:13
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 4 个回答

大猫1860

银虫 (小有名气)

【答案】应助回帖

增加金币我就翻译
笑一笑十年少
2楼2013-04-07 17:51:28
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

Rio2016

木虫 (小有名气)

【答案】应助回帖

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
yin198716: 金币+15, 翻译EPI+1, 有帮助 2013-04-08 17:15:02
Tumor angiogenesis is essential for tumor growth and metastasis and is triggered by a variety of proangiogenic factors, regulated by many angiogenic pathways.
肿瘤血管新生是肿瘤生长和转移所必需的,它由多种促血管形成因子触发并受多种血管新生通路调控。
The most important and best characterized is the VEGF pathway .
最重要和最有特点的就是VEGF通路。
Blockade of VEGF signaling inhibits tumor angiogenesis and growth in various preclinical models and having systemic effects .
在多种临床前模型中,阻断VEGF信号会抑制肿瘤血管新生和肿瘤生长,并且会有系统性的效应。
The effect of anti-VEGF strategy has been validated in randomized phase III clinical trials.
抗VEGF策略的作用在随机III期临床试验中得到巩固。
Disruption of VEGF signaling by using bevacizumab, a humanized anti-human VEGF antibody or sorafenib and sunitinib, 2 small chemical inhibitors of receptor-tyrosine kinases (RTK) including VEGF receptors  have yielded a significant improvement in progression-free survival but rarely in overall survival for patients with several types of cancers including metastatic colorectal cancer , advanced non–small cell lung cancer , metastatic breast cancer , advanced clear-cell renal-cell carcinoma  and advanced hepatocellular carcinoma .
用贝伐单抗(人源化的抗VEGF抗体)或用索拉非尼和舒尼替尼(受体络氨酸激酶的两种化学抑制剂)
破坏VEGF信号,可以显著改善无进展生存期,但对同时患有多种癌症病人的总体存活率的改善并不大,包括转移性结直肠癌、晚期非小细胞肺癌、转移性乳腺癌、晚期透明性肾细胞癌和晚期肝癌。

收录到淘贴专辑
寥寥数年、将就过活
3楼2013-04-08 10:26:41
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
信息提示
请填处理意见